The second pathway is the impairment of brain Pi homeostasis, either by hyperphosphatemia or by disrupted transport of phosphate in the brain; these patients suffering from this pathway defects may have mutations in SLC20A2, XPR1, or GNAS gene7,8,27 and usually show significantly increased CSF Pi levels. This evidence concerns the gene SLC20A2 and hyperphosphatemia.